Results 161 to 170 of about 7,765,953 (292)

Inhibition of human FcγRIII prevents platelet destruction in a dual-humanized murine model of FNAIT. [PDF]

Blood Adv
Tawhidi Z, Sachs UJ, Gil Gonzalez L, Khoury CJ, Tundidor Y, Wu XG, Cruz-Leal Y, Gupta A, Shehata N, Lieberman L, Ni H, Lazarus AH.   +11 more
europepmc   +1 more source

Harnessing ferroptosis from multilayer defense networks to nanoplatforms for specific cancer therapy

BMEMat, EarlyView.
Nanomaterials target metabolically‐regulated ferroptosis for cancer therapy. Iron‐based or alternative nanoplatforms integrate ferroptosis with chemotherapy, immunotherapy, or radiotherapy. They enable stimulus‐responsive therapies (photothermal, photodynamic, sonodynamic) activated by near‐infrared, light, or ultrasound, achieving potent synergistic ...
Xinyue Xu, Xuejian Wang, Wenyan Jiang, Wan Hairul Anuar Kamaruddin, Chunyan Fang, Pengfei Zhang   +5 more
wiley   +1 more source

Immune-mediated platelet refractoriness: Mechanisms, diagnostics, and therapeutic breakthroughs. [PDF]

Transfus Med
Ma L, Wu L, Xie J.
europepmc   +1 more source

Beyond wound sealing: A dual‐functional adhesive nanofiber membrane promoting coagulation and osteogenesis in extraction sites

BMEMat, EarlyView.
Inspired by the suction mechanics of octopus suckers, a dual‐layer nanofiber membrane integrates antibacterial protection, strong wet adhesion, and osteogenic support, offering a bioinspired strategy for effective hemostasis and alveolar bone preservation.
Huijing Ma, Liheng Gao, Hao Liang, Wentao Jiang, Junyi Wang, Jiajia Wang, Shuhan Duan, Lingxi Meng, Adilijiang Yimiti, Wenjie Zhang   +9 more
wiley   +1 more source

Integrated Immunological Engineering Platform for Scalable Production of iPSC-Derived Megakaryocytes. [PDF]

HLA
Dettmer R, Rovai A, Schröder L, Reinkens T, Wolkers W, Blasczyk R, Figueiredo C.   +6 more
europepmc   +1 more source

Tackling cancer stemness with nanotechnology in the era of precision medicine

BMEMat, EarlyView.
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo, Shun Yao, Lihui Meng, Chunyuan Chen, Yuechu Lucinda Lu, Rong Lu, Kashif Rafiq Zahid, Umar Raza, Qingzhi Wu, Wenli Chen   +9 more
wiley   +1 more source

Extracellular vesicle-mediated immune crosstalk in rheumatoid arthritis synovium: mechanistic insights and translational challenges. [PDF]

Front Immunol
Luo F, Yuan X, Zhou H, Wang Q, Chen C, Ling Y, Zheng J, Yao X, Ma W.   +8 more
europepmc   +1 more source

Harnessing blood clot as a native scaffold for orchestrating tissue repairs and regeneration

BMEMat, EarlyView.
The blood clot, owing to its dynamic composition and unique microenvironment, holds significant yet underappreciated potential for tissue engineering. This review systematically summarizes the pathophysiology of clot formation, the key regulatory factors shaping its microenvironment, and its applications in both pre‐clinical and clinical settings ...
Gao‐peng Dang, Yu‐zhu Wang, Yi‐fei Wang, Que Bai, Jia‐xin Hao, Zhi‐ting Li, Xiao‐qing Cao, Yu Wei, Yue Feng, Ji‐hua Chen, Franklin R. Tay, Rui‐bing Wang, Jun‐ting Gu, Li‐na Niu   +13 more
wiley   +1 more source

Pregnancy-induced Alloimmunization against Platelet Antigens. HLA and Human Platelet Antigens (HPA).

Journal of the Japan Society of Blood Transfusion, 2000
Enomoto, Takayuki, Maruoka, Hisako, Hanagaki, Sumio, Morita, Shoji, Shimamura, Masuhiro, Hando, Keiichi, Ishijima, Ayako, Yoshikawa, Akira, Yuasa, Shinji, Takahashi, Koki, Ohto, Hitoshi   +10 more
openaire   +2 more sources

Anti-HPA-1a IgG3 subclass antibodies induce strong platelet phagocytosis. [PDF]

Br J Haematol
Schmidt S, Xu X, Michel G, Kroll H, Bein G, Santoso S.   +5 more
europepmc   +1 more source